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Abstract
Background: Physical activity reduces cardiovascular mortality and morbidity. The World Health Organisation (WHO)
recommends children engage in 60 min daily moderate-to-vigorous physical activity (MVPA). The effect of compliance
with this recommendation on childhood cardiovascular risk has not been empirically tested. To evaluate whether
achieving recommendations results in reduced composite-cardiovascular risk score (CCVR) in children, and to examine
if vigorous PA (VPA) has independent risk-reduction effects.
Methods: PA was measured using accelerometry in 182 children (9–11 years). Subjects were grouped according to
achievement of 60 min daily MVPA (active) or not (inactive). CCVR was calculated (sum of z-scores: DXA body fat %,
blood pressure, VO2peak, flow mediated dilation, left ventricular diastolic function; CVR score ≥1SD indicated ‘higher
risk’). The cohort was further split into quintiles for VPA and odds ratios (OR) calculated for each quintile.
Results: Active children (92 (53 boys)) undertook more MVPA (38 ± 11 min, P < 0.001), had greater VO2peak
(4.5 ± 0.8 ml/kg/min P < 0.001), and lower fat % (3.9 ± 1.1 %, P < 0.001) than inactive. No difference were observed
between active and inactive for CCVR or OR (P > 0.05). CCVR in the lowest VPA quintile was significantly greater than
the highest quintile (3.9 ± 0.6, P < 0.05), and the OR was 4.7 times higher.
Conclusion: Achievement of current guidelines has positive effects on body composition and cardiorespiratory fitness,
but not CCVR. Vigorous physical activity appears to have beneficial effects on CVD risk, independent of moderate PA,
implying a more prescriptive approach may be needed for future VPA guidelines.
Keywords: Physical activity guidelines, Moderate/vigorous physical activity, Clustered cardiovascular risk
Background
Physical activity (PA) predicts cardiovascular disease
(CVD) morbidity and mortality [1] and prevents and/or
reduces traditional and emerging cardiovascular (CV)
risk factors in healthy and high risk children [2, 3]. The
American College of Sports Medicine originally pub-
lished PA recommendations for young people in 1988,
albeit based on their adult recommendations [4]. These
guidelines and the supporting evidence base have been
re-evaluated numerous times in an attempt to account
for advances in PA and CVD risk factor measurement
techniques [5, 6]. Most recently, The World Health
Organization (WHO) updated their paediatric PA
recommendations [7] to reflect findings from a review
by Janssen and LeBlanc [2] and the European Youth
Heart Study [8], which suggested that previous guide-
lines underestimated the activity necessary to reduce
CVD risk in young people. The WHO guidelines now
suggest children aged 5–17 years accumulate 60 min of
moderate-to-vigorous physical activity (MVPA) daily, in
addition to everyday physical activities, and that vigorous
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intensity physical activity (VPA) should be incorporated
at least three times per week.
Whilst the updated guidelines address some of the limi-
tations of previous versions [3] and advocate more PA than
previously, numerous limitations remain. No study has em-
pirically tested guidelines by comparing CVD risk in chil-
dren who do achieve them to those who do not, whilst
both Andersen et al. and Strong et al. [3, 9] provide com-
prehensive reviews on the dose response relationship, and
make important recommendations for childhood PA, they
do not test the validity of current recommendations using
empirical data. Secondly, current guidelines are based on
self-report PA, which has numerous limitations, and do
not include novel CVD risk markers as outcome measures.
Andersen et al. [3] addressed these limitations via inclusion
of objective PA data, and novel inflammatory markers.
However, endothelial and diastolic dysfunction are yet to
be included in such analyses despite the crucial role each
plays in the development of CVDs [10], their strong prog-
nostic capacity in predicting CV events [11, 12], and clear
associations with PA [13–15]. Finally, evidence suggests
VPA may have potent effects on CVD risk [16], yet, WHO
recommendations on VPA specifically, remain vague. With
these limitations in mind, we sought to evaluate whether
adherence to current WHO recommendations equates to a
reduction in CVD risk in children. Secondly, we aimed to
examine if, and in what quantity, VPA provides additional
CVD risk benefits beyond moderate PA (MPA).
Methods
Subjects
Data were generated by the REACH Year 6 and the Ac-
tive City of Liverpool, Active Schools and SportsLinx
(A-CLASS) studies (Liverpool, UK). Fourteen schools
from areas of social deprivation (IMD >40) participated
across the studies; all 9–11 year old children were in-
vited to participate. Following parental consent and
medical screening, 233 children (10.8 ± 0.6 years; 100
boys) were studied. All were healthy and not suffering
from cardiovascular/metabolic conditions. Informed
written parent/guardian consent and child assent were
obtained. Ethical approval was obtained from Liverpool
John Moores University Ethics Committee. All data col-
lection methods were standardised between the studies
unless otherwise stated.
Experimental design
Initially, children visited the laboratory to complete
measurements, including anthropometric tests and dual-
energy X-ray absorptiometry (DXA), VO2peak testing,
vascular endothelial function and echocardiography. As-
sessments were made in a quiet temperature-controlled
room at the same time of day, following a morning fast
and avoidance of strenuous PA for 24 h. Subsequently, PA
was assessed via accelerometry over 7 consecutive days.
Measurements and post-test analysis
Anthropometry and body composition
Body mass (kg), stature and sitting height (cm) were mea-
sured using standard methods. Somatic maturity was esti-
mated by calculating time to peak height velocity (TPHV)
using gender specific regression equations [17, 18].
A DXA scan (QDR discovery A, Hologic, MA) was
completed according to standardized manufacturer pro-
cedures. Participants were scanned in the supine pos-
ition while wearing t-shirt and shorts.
Vascular function
Following 20 min supine rest, brachial artery diameter,
blood flow and shear rate were assessed via high-
resolution ultrasonography (Acuson, Aspen, Penn and
Terason, T3000, Aloka, UK) prior to, and following,
5 min forearm ischaemia. Methods were identical to
those previously described [14] in accordance with best
practice guidelines [19].
Left ventricular diastolic function
Following 10 min of quiet rest in the left lateral decubitus
position. Left ventricular diastolic function was assessed
via echocardiography (Mylab30CV system, ESAOTE,
Italy). All system settings including gain, filter, PRF, sector
size and depth were adjusted to optimise image quality.
Mitral inflow was assessed from the apical four-chamber
via a 2 mm sample volume at the tips of the mitral leaflets,
parallel with flow, peak early (E) and late/atrial (A) veloci-
ties were obtained and E/A ratio reported.
Cardiorespiratory fitness
During each protocol VO2 and VCO2 were measured
breath-breath via an online gas analysis system (Jaeger
Oxycon Pro, Viasys Health Care, Warwick, UK). Heart
rate (HR) was monitored continuously (Polar, Kempele,
Finland).
A-CLASS study method Peak oxygen uptake (VO2peak)
was determined during a discontinuous treadmill exercise
test which involved walking and running until volitional
exhaustion. The test consisted of 3 min stages, followed
by a 30-s rest interval. Peak VO2 was accepted as the high-
est 15-s averaged oxygen uptake achieved during the test
with a respiratory exchange ratio ≥1.05 and/or HR ≥195
beats.min−1.
REACH study method To account for differences in
biological age and limb length, treadmill speeds were in-
dividually calibrated by anchoring speeds to set Froude
(Fr) numbers as described previously [20]. A continuous
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protocol was used unitl volitional exhaustion occurred.
Peak VO2 was defined as the highest 15-s average
oxygen uptake achieved with a respiratory exchange
ratio >1.05 and/or HR > 199 beats/min−1.
Physical activity
Physical activity was objectively measured for 7 consecu-
tive days using a hip mounted uni-axial accelerometer
(GT1M model, ActiGraph, FL, USA) set to 5 s epochs.
Children wore the accelerometer during all waking
hours, except during water-based activities. Consecutive
zero counts >20 min were removed from analysis as
non-wear. Minimum wear time for inclusion in data
analysis was 9 h/day for any 3 days of the week [21].
Accelerometer data reduction was performed using Acti-
Life v 6.1.4 (ActiGraph, LLC, 2010–2012). The Evenson
cut-points [22] were used to define PA and sedentary in-
tensity thresholds [23]. Total time spent in each PA/SB
threshold for each valid day was divided by the total
number of valid days. Subjects were then split into
groups; those who achieved a daily average of 60 min
MVPA (active) and those who did not (inactive [24]).
Statistical analysis
All statistical analysis were performed using SPSS (18.0,
Chicago, Illinois) software. Statistical significance was set
at P < 0.05. Variables were tested for normality when
grouped by sex and PA level using the Kolmogorov-
Smirnov test. DBP and E/A ratio data were normalised
by log transformation and FMD using square root trans-
formation. All analyses were performed at the cohort
level initially; additional analyses were then performed
by gender.
Gender specific standardized z-scores for percentage
body fat, VO2peak, FMD, systolic blood pressure and E/A
ratio were calculated and inverted where necessary, z-
scores were summed to create a composite CVD risk
score (CCVR). Pearson’s correlation analysis was used to
assess relationships between z scores (Table 1). Children
with CCVR ≥1 SD were defined as ‘higher risk’ [8]. Differ-
ences in individual CVD risk factors and CCVR between
the active and inactive group, boys and girls were assessed
using an independent t-test, or analysis of covariance
(ANCOVA), with TPHV as a covariate (continuous vari-
ables), or a chi-square test (discrete variables).
The cohort was split into quintiles according to VPA.
Differences in individual CVD risk factors and CCVR
across quintiles were assessed using ANCOVA with MPA,
sedentary behaviour and TPHV as covariates, or using a
chi-square test (discrete variables). Logistic regression was
then used to obtain odds ratios for each group (Boys/Girls,
Active/Inactive and all VPA quintiles).
Results
Subject characteristics
Of the 233 children initially recruited, 182 children met
criteria for accelerometer wear time coupled with
adequate vascular measurements. Those who did not
meet criteria were removed from analyses, there were no
differences between included and excluded children across
measured variables. Baseline characteristics are presented
in Table 2. Boys had significantly higher VO2peak and
DBP, whilst girls were significantly closer to PHV and had
higher percentage body fat. Additionally, boys engaged in
significantly more MVPA and VPA than girls (Table 2).
Active vs. inactive analysis
Inactive children had significantly higher percentage
body fat and lower VO2peak compared to active chil-
dren. No other significant differences were found be-
tween the two groups (Table 3). The odds for being
‘higher risk’ were 1.9 (95 % CI: 0.8–4.3) times higher in
the inactive group than the active group (p = 0.126).
Gender analysis
Boys were more active than girls (p < 0.001, Table 3) and
active boys engaged in more MVPA than active girls
(11 min/day, p = 0.004). Active boys had significantly
lower percentage body fat and CCVR, and higher
VO2peak than inactive boys (Table 3). Thirty seven per-
cent of inactive boys were classed as ‘at risk’ compared
to 10 % of the active boys (p = 0.028), the odds of being
at risk were 5.1 times higher in the inactive boys than
the active boys (95 % CI: 1.4 – 19.1, p = 0.015). Active
Table 1 Correlations between z scores used to calculate CCVD risk score
Z score VO2max (ml/kg/min) Fat % (DXA) SBP (mmHg) FMD % E/A ratio
r p r p r p r p r p
VO2max (ml/kg/min) 1 −0.691 0.000 −0.163 0.036 0.025 0.743 0.173 0.027
Fat % (DXA) −0.691 0.000 1 0.239 0.001 −0.056 0.448 −0.230 0.002
SBP (mmHg) −0.163 0.036 0.239 0.001 1 −0.112 0.134 −0.068 0.370
FMD % 0.025 0.743 −0.056 0.448 −0.112 0.134 1 0.072 0.340
E/A ratio 0.173 0.027 −0.230 0.002 −0.068 0.370 0.072 0.340 1
Fat % percentage of body fat, DXA dual-energy X-ray absorptiometry, SBP systolic blood pressure, VO2max peak oxygen uptake, FMD flow mediated dilation, E/A
ratio ratio between passive and active filling of the left ventricle (cm/s)
Füssenich et al. BMC Public Health  (2016) 16:67 Page 3 of 7
girls engaged in significantly less sedentary behaviour
compared to inactive girls (p < 0.001), no further differ-
ences were found.
Vigorous physical activity
Comparisons were made between the highest VPA quin-
tile (Q5) and all others (Table 4). CCVR was significantly
elevated in Q1. Q1, Q2 and Q4 had significantly higher
percentage body fat. VO2peak was significantly lower in
Q1 and Q2. The OR was significantly higher in Q1 than
Q5 (OR 4.7, p < 0.05, Table 4; Fig. 1). When quintiles were
examined by gender, no significant differences were found
between quintiles (difference between Q1 and Q5: 6.1
(95 % CI: 0.6 – 59.5, p < 0.05) and 7.4 (95 % CI: 0.7 – 80.0,
p < 0.05), in girls and boys respectively).
Discussion
To our knowledge, this is the first study which used a
composite risk score which included novel pre-clinical
markers of CVD risk to empirically evaluate the effects
of adherence to the current WHO PA guidelines for
children, and provide novel information regarding rec-
ommendations for VPA. Our findings from the whole
cohort indicate no difference in CCVR between active
and inactive asymptomatic 9–11 year old children, im-
plying current guidelines may underestimate the PA ne-
cessary to reduce CCVR. Although achieving WHO PA
recommendations did have beneficial effects on
VO2peak and adiposity. Furthermore, VPA appeared to
provide health benefits in addition to those of MPA,
Table 2 Descriptive statistics
Group Girls (105) Boys (77)
Age (years) 10.8 (0.6) 10.7 (0.6) 10.8 (0.6)
Height (cm) 145.0 (8.0) 145.4 (7.8) 144.6 (8.3)
Body mass (kg) 41.7 (10.6) 42.3 (10.2) 40.9 (11.0)
Maturity offset (TPHV) −2.51 (1.23) −2.30 (1.44) −2.79 (.79)
BMI (kg/m2) 19.6 (3.5) 19.8 (3.3) 19.3 (3.7)
Fat % (DXA) 27.7 (6.7) 29.4 (5.7) 25.2 (7.2)a
SBP (mmHg) 106 (11) 105 (11) 108 (12)
DBP (mmHg) 63 (6) 62 (5) 64 (6)a
VO2max (ml/kg/min) 46.0 (6.9) 43.5 (6.1) 49.6 (6.4)
a
FMD % 8.9 (4.1) 8.9 (4.1) 8.9 (4.3)
E/A ratio 2.1 (0.5) 2.1 (0.4) 2.1 (0.5)
CCVD risk −0.04 (2.94) 0.12 (2.98) −0.27 (2.89)
MVPA (min) 64 (25) 56 (20) 75 (27)a
VPA (min) 25 (13) 22 (12) 30 (13)a
Sedentary (min) 605 (148) 608 (80) 600 (209)
MPA/VPA ratio 1.7 (0.6) 1.8 (0.7) 1.7 (0.6)
TPHV time to peak height velocity, BMI body mass index, Fat % percentage of body
fat, DXA dual-energy X-ray absorptiometry, SBP systolic blood pressure, DPB diastolic
blood pressure, VO2max peak oxygen uptake, FMD flow mediated dilation, E/A ratio
ratio between passive and active filling of the left ventricle (cm/s), CCVD risk
composite cardio vascular disease risk score as sum of z-scores, MVPA moderate
to vigorous physical activity, VPA vigorous physical activity. All data expressed as
mean (SD). aSignificant difference between boys and girls <0.05
Table 3 Cardiovascular risk factors in the active and inactive
Group Girls Boys
Inactive
(n = 90)
Active
(n = 92)
p Inactive
(n = 66)
Active
(n = 39)
p Inactive
(n = 24)
Active
(n = 53)
p
Fat % 29.6 (5.9) 25.7(7.0) >0.001 29.2 (5.9) 29.8 (5.4) 0.90 30.7 (5.8) 22.7 (6.5) >0.001
SBP 106 (12) 106 (12) 0.89 106 (10) 104 (11) 0.58 108 (11) 108 (12) 0.97
Baseline artery diameter (mm) 3.1 (0.3) 3.1 (0.5) 0.73 3.0 (0.3) 3.0 (0.4) 0.67 3.2 (0.4) 3.1 (0.5) 0.90
FMD% 9.1 (4.1) 8.7 (4.2) 0.45 9.1 (4.1) 8.6 (3.9) 0.65 9.2 (4.0) 8.8 (4.4) 0.44
VO2max 43.70 (6.1) 48.3 (6.9) >0.001 43.1 (6.3) 44.2 (5.7) 0.16 45.56 (5.2) 51.2 (6.2) 0.01
E/A ratio 2.2 (0.5) 2.1 (0.4) 0.78 2.2 (0.5) 2.2 (0.4) 0.36 2.1 (0.6) 2.2 (0.4) 0.64
CCVD risk 0.36 (2.95) −0.43 (2.90) 0.40 0.09 (2.93) 0.19 (3.12) 0.87 1.22 (2.92) −0.85 (2.70) 0.01
At risk (%) 23 13 0.35 18 18 0.99 37 10 0.03
OR CCVD risk 1.9 1.0 0.13 1.0 1.0 0.99 5.1 1.0 0.02
MVPA (min) 45 (10) 83 (21) >0.001 45 (10) 77 (17) >0.001 46 (9) 88 (22) >0.001
VPA (min) 16 (6) 33 (14) >0.001 16 (6) 30 (15) >0.001 17 (5) 36 (12) >0.001
MPA/VPA ratio 1.9 (0.7) 1.6 (0.6) >0.001 1.9 (0.7) 1.7 (0.7) 0.18 1.9 (0.6) 1.6 (0.5) >0.01
Sedentary (min) 625 (80) 585 (192) 0.03 629 (84) 573 (59) >0.001 613(68) 594 (248) 0.53
Inactive = those who did not achieve the recommended 60 min MVPA per day. Active = those who achieved the recommended 60 min MVPA per day
Fat % percentage of body fat, SBP systolic blood pressure, BD baseline diameter of brachial artery in mm, FMD flow mediated dilation, VO2max peak oxygen
uptake, E/A ratio ratio between passive and active filling of the left ventricle (cm/s), CCVD risk clustered cardio vascular disease risk score as sum of z-scores, At risk percentage
of children with more than 1SD in the CCVD risk score, OR CCVD risk odds ratio for being at risk compared to the active group, MVPAmoderate to vigorous physical activity
in minutes/day, VPA vigorous physical activity in minutes/day, sedentary sedentary behaviour in hours/day. All data expressed as mean (SD)
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suggesting it necessary to incorporate a more specific
recommendation regarding the VPA.
Active boys have 1/5 of the risk compared to inactive
boys (Table 3), whereas no differences were found be-
tween active and inactive girls. We observed a significant
difference in MVPA between active boys and active girls,
(11 ± 5 min, p = 0.004; Table 3) and active girls had a
similar risk factor profile to inactive girls and inactive
boys. This suggests that gender differences in risk factors
may not be resultant of gender per se, but are possibly
Table 4 Cardiovascular risk factors in quintiles of vigorous physical activity
Whole
cohort
Number VPA MPA Sedentary MPA/VPA ratio CCVD risk At risk (%) OR Fat % FMD% SBP VO2max E/A ratio
1 36 11 (2)a 27 (10)a 632 (91) 2.5 (0.8)a 1.31 (3.26)a 34.5 %a 4.7a 31.9 (1.2)a 8.4 (3.8) 106 (12) 42.3 (6.7)a 2.0 (0.3)
2 37 17 (2)a 34 (8)a 613 (64) 2.0 (0.5)a 0.23 (2.93) 20.7 % 2.1 29.3 (1.0)a 9.5 (4.9) 104 (12) 43.6 (5.3)a 2.2 (0.4)
3 36 22 (2)a 36 (7)a 603 (69) 1.6 (0.3) −0.40 (2.81) 17.2 % 1.6 27.1 (1.0) 8.3 (3.7) 105 (9) 46.7 (6.7) 2.3 (0.6)
4 37 29 (2)a 43 (11)a 587 (56) 1.5 (0.4) −0.06 (2.58) 17.2 % 1.7 27.5 (1.0)a 9.1 (4.2) 108 (12) 46.9 (6.9) 2.0 (0.3)
5 36 45 (14) 56 (13) 587 (303) 1.3 (0.3) −1.22 (2.71) 10.3 % 1 22.4 (1.3) 9.3 (4.0) 106 (11) 51.0 (5.8) 2.1 (0.5)
Boys
1 15 13 (2)a 30 (11)a 613 (72) 2.3 (0.8)a 1.11 (3.38) 36.4 % 7.4 30.0 (7.0) 8.8 (4.5) 105 (13) 47.5 (6.1) 1.9 (0.3)
2 16 20 (2)a 39 (6)a 590 (73) 1.9 (0.3)a 0.25 (2.63) 18.8 % 3.0 27.4 (6.5) 9.0 (4.0) 106 (11) 47.1 (7.2) 2.3 (0.6)
3 15 28 (3)a 42 (11)a 586 (22) 1.5 (0.3) −0.20 (2.68) 15.4 % 2.4 24.7 (7.2) 7.3 (3.7) 111 (13) 50.8 (5.7) 2.1 (0.4)
4 16 36 (2)a 51 (9)a 675 (42) 1.4 (0.2) −0.72 (3.04) 14.3 % 2.2 23.7 (6.9) 10.0 (5.3) 108 (10) 49.7 (5.5) 2.2 (0.5)
5 15 50 (9) 63 (14) 530 (48) 1.3 (0.2) −1.56 (2.56) 7.1 % 1 20.2 (5.4) 9.6 (3.7) 110 (11) 53.0 (6.1) 2.2 (0.4)
Girls
1 21 10 (2)a 25 (8)a 652 (99)a 2.5 (0.8)a 0.51 (3.16) 27.8 % 6.2 29.6 (6.8) 8.9 (4.0) 107 (11) 42.3 (5.9) 2.1 (0.3)
2 21 15 (1)a 33 (9)a 625 (75) 2.2 (0.6)a 0.98 (3.73) 30.0 % 6.9 32.2 (6.3)a 8.3 (3.9) 103 (14) 40.7 (5.9) 2.2 (0.5)
3 21 20 (1)a 31 (6)a 601 (57) 1.6 (0.3) −0.69 (2.25) 5.6 % 0.9 28.9 (5.3) 10.1 (4.6) 104 (8) 44.0 (5.4) 2.3 (0.5)
4 21 26 (2)a 39 (8) 605 (69) 1.5 (0.3) 0.43 (2.71) 20.0 % 4.0 29.3 (4.6) 7.7 (3.8) 106 (9) 45.6 (5.5) 2.0 (0.5)
5 21 37 (18) 45 (13) 559 (69) 1.3 (0.7) −0.79 (2.62) 5.9 % 1 27.2 (4.8) 9.6 (3.9) 104 (11) 45.3 (6.9) 2.1 (0.3)
VPA vigorous physical activity (min/day), MPA moderate physical activity (min/day), CCVD risk clustered cardiovascular disease risk score as sum of z-scores, At risk
% of children with more than 1SD in the CCVD risk score, OR CCVD risk odds ratio for being at risk compared to the active group, Fat % percentage of body fat,
FMD% flow mediated dilation, SBP systolic blood pressure, VO2max peak oxygen uptake, E/A ratio ratio between passive and active filling of the left ventricle (cm/s). All
data expressed as mean (SD). CCRD risk score consists of Fat%, FMD%, SBP, VO2Max, E/A ratio. aSignificant difference compared to most active quintile <0.05
Fig. 1 Odds ratios for being at risk by quintiles of physical activity. *Significant difference between VPA quintile 1 and 5, P < 0.05. No significant
differences across MPA quintiles. VPA = vigorous physical activity, MPA =moderate physical activity
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determined by differences in PA levels [2, 3, 25, 26]. Al-
though active girls engaged in daily MVPA in excess
60 min, this appears insufficient to confer the CVD risk
benefits afforded by the active boys. Our data suggest
77 min MVPA was insufficient for CCVR risk reduction,
whilst 88 min MVPA resulted in a reduction, supporting
previous conclusions from Andersen et al. [8] that PA
guidelines should be higher than the current 60 min
MVPA/day. Furthermore, our data raise the question of
whether children’s PA guidelines should be gender
specific; little is known about gender specific dose
responses to PA, further investigation therefore appears
to be warranted.
In agreement with adult literature, which demonstrate
that VPA is a more meaningful predictor of cardiometa-
bolic risk than MPA [27], we provide evidence that VPA
may afford additional CVD risk reduction in children.
CCVR ORs were ~5 times higher in Q1 compared to Q5
(p < 0.05), whilst no differences were observed across
MPA quintiles (Fig. 1). The largest reduction in risk was
evident between Q1 and Q2 (VPA 11 ± 2 vs 17 ± 2 min,
respectively, p > 0.05; Table 4) and although this risk re-
duction is non-significant in this small study, we suggest
that a reduction in odds ratio of ~50 % is a clinically
meaningful finding. On this basis, 17 min of VPA per
day (Q2), equating to around 2 h VPA/week is needed to
reduce CVD risk in pre-pubertal children.
In contrast to percent body fat and VO2 peak, there was
no significant difference between active and inactive
groups or across VPA quintiles for E/A ratio or FMD.
Whilst the inclusion of FMD and E/A ratio in analysis
provides novel information, these surrogate markers do
not appear to enhance the predictive power of the CCVR
model in this cohort, One possible interpretation of this
finding is that diastolic and endothelial function are not
modulated by PA, however a wealth of previous findings
contradict this hypothesis [13, 14, 28]. A more plausible
hypothesis relates to the dose of activity the inactive chil-
dren are exposed to; 45 min MVPA/day, including 17 min
of VPA, whilst they fall short of WHO guidelines for
MVPA, this level of VPA may be adequate to prevent de-
terioration of endothelial and diastolic function. These
data lend support to our recommendations above that
17 min VPA/day is cardioprotective, and previous findings
from our group which imply that VPA is more important
for endothelial function than other PA intensities [14].
Further research is needed to confirm or refute the role of
VPA in the modulation of these variables.
This study advances knowledge of the complex relation-
ship between PA and CVD risk in children, as it investi-
gates, for the first time, the utility of adding novel CVD
surrogates, to a composite score of ‘pre-clinical’ markers
to estimate CVD risk. As CVD risk factors tend to cluster
in sedentary and obese individuals, stronger associations
between CVD risk and PA may be observed when a com-
posite CVD risk score is generated. Additionally, as we
measured PA levels objectively we are confident of greater
measurement precision than the self-report PA data from
which the current WHO guidelines are derived, nonethe-
less given the sporadic nature of children’s PA patterns, it
is plausible that using an epoch length of 5 s may result in
an underestimation of VPA. Furthermore, a lack of parity
in PA measurement techniques and accelerometer cut
points used between this and other studies makes com-
parison and interpretation difficult. Various confounders
including diet, smoking status and socioeconomic status
were not accounted for in our analyses as we lack the data
to do so. Finally, although our findings lend support to the
previous recommendations that 60 min daily MVPA may
not be enough for children of this age [8], given the rela-
tively small sample size and limited number of children
that achieved guidelines, findings should be interpreted
with caution.
Conclusions
In our study of asymptomatic 9–11 year old children,
there were no differences between CCVR of children
who undertook 60 min MVPA per day in accordance
with WHO recommendations, and those who did not.
This implies that current recommendations may be an
underestimation of the PA necessary to reduce clustered
CVD risk. A gender difference between the CVD risk in
active and inactive children, raises the possibility that
gender specific guidelines may be needed, although
much work is needed to determine if these differences
are a result of gender specific responses to PA or sex dif-
ferences in PA level. Finally, VPA appears to provide
CCVR benefits beyond those afforded by MPA, with
data suggesting that 17 min VPA/day may provide clin-
ically meaningful CVD risk reductions. Taken together
these findings suggest that in order to reduce CVD risk,
the current guidelines should be updated to increase the
amount of MVPA recommended, and to prescribe a
daily amount of VPA.
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